Neurotoxin injections can help with a plethora of cosmetic and medical problems. It relaxes muscles, reduces the appearance of fine lines, smoothens skin texture, and even targets and inhibits excessive sweating and migraines. However, the biggest downside to investing in any neurotoxin is that its benefits only last for a short period of time (i.e. months) before the body metabolizes the injection. Basic maintenance can become tiresome and – most importantly – expensive if you decide to re-service after every wear.
But we have good news: a new neurotoxin is on the horizon that could revolutionize the beauty therapy game: meet, DaxibotulinumtoxinA, aka, Daxi.
“DaxibotulinumtoxinA is poised to disrupt the neurotoxin market. The consumer experience with neuromodulator products has remained the same since botulinum toxin A treatment was first introduced more than 30 years ago,” said a representative of Revance, Daxi’s parent biotech company, in a statement. wrote in the email lure“We believe that a long-acting neuromodulator product will fill a significant, unmet need in both aesthetics and therapy.”
But before you make an appointment with a dermatologist, you should know that this new neurotoxin is still awaiting approval from the U.S. Food and Drug Administration (FDA). Before Daxi enters the clinic, we turn to the experts to learn everything about Daxi, so read on to find out the details.
Meet the experts:
What is Daxi and how does it work?
Daxi is a novel botulinum toxin type A (BoNTA) that is in clinical development for therapeutic and cosmetic purposes, explained Sabine Lovell, MD, a board-certified plastic surgeon at Muse Plastic Surgery in Atlanta, Georgia. Similar to other neurotoxin treatments like Botox, Dysport, Xeomin, and Jeuveau, Daxi blocks the nerve signals that cause muscles to contract, reducing painful muscle spasms that can cause the skin to tighten.
“Daxi can help smooth fine lines on the face for a more youthful appearance,” says Bruce Katz, MD, a board-certified dermatologist at the Juva Skin and Laser Center in New York City. Dr. Katz, who was also one of the first dermatologists to rejoice in the clinical study, explained that it’s formulated with a proprietary protein that attaches muscle-paralyzing toxins for longer-lasting results.